首都医药
首都醫藥
수도의약
CAPITAL MEDICINE
2014年
16期
46-47
,共2页
超声内镜%上消化道粘膜下肿瘤%内镜微创治疗
超聲內鏡%上消化道粘膜下腫瘤%內鏡微創治療
초성내경%상소화도점막하종류%내경미창치료
endoscopic ultrasonography(EUS)%upper gastrointestinal submucosal tumors(SMT)%endoscopic mucosal resection (EMR)
目的:评价超声内镜检查对上消化道粘膜下肿瘤的诊断价值,探讨超声内镜指导下内镜微创治疗上消化道粘膜下肿瘤的应用价值。方法对内镜发现的210例上消化道粘膜下肿瘤进行超声内镜检查,根据其结果选择不同治疗方案,其中145例采用内镜微创治疗及外科手术切除。术后定期内镜随访。结果210例上消化道粘膜下肿瘤经超声内镜检查,诊断胃肠道平滑肌瘤78例、间质瘤84例、脂肪瘤20例、异位胰腺19例、囊肿6例、神经内分泌瘤3例。120例采用内镜微创治疗,25例行外科手术切除。超声内镜诊断与术后病理性质符合率为87.6%,来源层次符合率87.6%。103例内镜术后随访1~24个月,未见复发。结论超声内镜对上消化道粘膜下隆起病变的来源及性质判断有较高准确性,且为隆起病变在内镜下选择何种治疗方案提供重要依据。
目的:評價超聲內鏡檢查對上消化道粘膜下腫瘤的診斷價值,探討超聲內鏡指導下內鏡微創治療上消化道粘膜下腫瘤的應用價值。方法對內鏡髮現的210例上消化道粘膜下腫瘤進行超聲內鏡檢查,根據其結果選擇不同治療方案,其中145例採用內鏡微創治療及外科手術切除。術後定期內鏡隨訪。結果210例上消化道粘膜下腫瘤經超聲內鏡檢查,診斷胃腸道平滑肌瘤78例、間質瘤84例、脂肪瘤20例、異位胰腺19例、囊腫6例、神經內分泌瘤3例。120例採用內鏡微創治療,25例行外科手術切除。超聲內鏡診斷與術後病理性質符閤率為87.6%,來源層次符閤率87.6%。103例內鏡術後隨訪1~24箇月,未見複髮。結論超聲內鏡對上消化道粘膜下隆起病變的來源及性質判斷有較高準確性,且為隆起病變在內鏡下選擇何種治療方案提供重要依據。
목적:평개초성내경검사대상소화도점막하종류적진단개치,탐토초성내경지도하내경미창치료상소화도점막하종류적응용개치。방법대내경발현적210례상소화도점막하종류진행초성내경검사,근거기결과선택불동치료방안,기중145례채용내경미창치료급외과수술절제。술후정기내경수방。결과210례상소화도점막하종류경초성내경검사,진단위장도평활기류78례、간질류84례、지방류20례、이위이선19례、낭종6례、신경내분비류3례。120례채용내경미창치료,25례행외과수술절제。초성내경진단여술후병이성질부합솔위87.6%,래원층차부합솔87.6%。103례내경술후수방1~24개월,미견복발。결론초성내경대상소화도점막하륭기병변적래원급성질판단유교고준학성,차위륭기병변재내경하선택하충치료방안제공중요의거。
Objective To evaluate the value of endoscopic ultrasonography(EUS) in the diagnosis and therapy of upper gastrointestinal submucosal tumors(SMT). Methods 210 cases of upper gastrointestinal SMT were detected by EUS. A total of 145 cases were treated by different theraputic techniques according to the results of EUS.All of the patients were followed up regularly by endoscopy and EUS after treatments. Results The 210 cases of upper gastrointestinal SMT diagnosed by EUS including 78 leiomyomas, 84 GISTs, 20 lipomas, 19 etopic pancreases, 6 cysts and 3 Neuroendocrine tumors. 120 patients are received endoscopic therapy and 25 patients are received surgical resection. the diagnostic accuracy of qualitation and layer origin of EUS for SMT is 87.6%and 87.6%respectively. 103 cases were followed up postoperatively with no recurrence in 1-24 months. Conclusions EUS is capable of delineating the origin and property of upper gastrointestinal submucosal tumors. It can provide important evidence to manage SMT under endoscopy effectively and safely.